Monitoring vascular health using advanced imaging techniques
Cellular-level Vascular Oculomics (CVO) for monitoring systemic vascular health
This study is testing a new way to take detailed pictures of your blood vessels to help check your overall vascular health, and it's looking for patients to join in and see if this technology can help spot problems that might lead to conditions like Alzheimer's disease.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11096301 on NIH RePORTER |
What this research studies
This research focuses on developing a new imaging technology called Cellular-level Vascular Oculomics (CVO) to monitor systemic vascular health. It involves creating specialized devices and software that can capture detailed images of blood vessels and analyze them using artificial intelligence. Patients will be recruited to participate in clinical trials at multiple sites, where their vascular health will be assessed through these innovative imaging techniques. The goal is to establish a reliable method for detecting vascular issues that could lead to conditions like Alzheimer's disease.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals at risk for Alzheimer's disease or those with existing vascular health issues.
Not a fit: Patients with no vascular health concerns or those who are not at risk for Alzheimer's disease may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier detection and better management of vascular health, potentially reducing the risk of Alzheimer's disease and other related conditions.
How similar studies have performed: Other research has shown promise in using advanced imaging techniques for vascular health monitoring, suggesting that this approach could be effective.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Fawzi, Amani a — Northwestern University at Chicago
- Study coordinator: Fawzi, Amani a
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.